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Background: We examined the safety and efficacy of pulmonary vein isolation (PVI) compared to optimal medical therapy in patients with severe 
heart failure (HF) and persistent atrial fibrillation (AF).
Methods: Patients with symptomatic HF, radionuclide LVEF < 35% and persistent AF were randomized to PVI or continued medical therapy. At 3 
months patients still in AF had repeat PVI. Cardiovascular magnetic resonance imaging (CMR), B-type natriuretic peptide (BNP) and quality of life 
were measured at baseline and 6 months. Primary endpoint was change in CMR LVEF from baseline to 6 months.
Results: 41 patients were randomized (Table). PVI was complicated by cardiac tamponade in 2 patients and stroke in 1. By intention to treat, there 
was no difference in the change in CMR LVEF, BNP or quality of life at 6 months (Table). Patients in sinus rhythm at 6 months had a greater change 
in CMR LVEF than those in AF (+10.4% v +1.5%, p=0.008).
Conclusions: In patients with severe HF and persistent AF, PVI achieved sinus rhythm in 50% at 6 months, with a major complication rate of 11%. 
Patients in sinus rhythm at 6 months had a markedly improved LVEF compared with those remaining in AF. 
Intention to treat analysis AF v sinus rhythm at completion
Medical therapy Ablation p-value AF at end
Sinus rhythm 
at end
p-value
n 19 22 28 10
Mean age, yr. (SD) 64.4 (8.3) 62.3 (6.7) 63.9 (8.0) 60.7 (6.7)
Mean AF duration, months (SD) 64 (48) 44 (37) 58 (46) 34.4 (26.3)
NYHA Class III % 90 91 89 90
Sinus rhythm, at 6 months, % 0 50 0 100
Mean baseline CMR LVEF, % (SD) 42.9 (9.4) 36.1 (13.0) 39.2 (10.4) 38.2 (14.7)
Change in CMR LVEF over 6 mths, % (SD) 2.8 (6.7) 4.5 (11.1) 0.6 1.5 (7.7) 10.4 (10.4) 0.008
Mean baseline BNP, pg/mL (SD) 1807 (1648) 2499 (2104) 2215 (1898) 2220 (2202)
Change in BNP over 6 mths, pg/mL (SD) +85 (648) -196 (1469) 0.45 -21 (708) -179 (1975) 0.27
